John D. Prugh

686 total citations
23 papers, 528 citations indexed

About

John D. Prugh is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, John D. Prugh has authored 23 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 9 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in John D. Prugh's work include Platelet Disorders and Treatments (4 papers), Plant biochemistry and biosynthesis (4 papers) and Microbial Natural Products and Biosynthesis (3 papers). John D. Prugh is often cited by papers focused on Platelet Disorders and Treatments (4 papers), Plant biochemistry and biosynthesis (4 papers) and Microbial Natural Products and Biosynthesis (3 papers). John D. Prugh collaborates with scholars based in United States. John D. Prugh's co-authors include A. A. Deana, R. B. Levine, Kimiko Della Croce, Robert L. Smith, George D. Hartman, Alfred W. Alberts, Jesse W. Huff, Pierre Mallorga, Stuart R. Michelson and Harvey Schwam and has published in prestigious journals such as Journal of Medicinal Chemistry, Developmental Biology and The Journal of Organic Chemistry.

In The Last Decade

John D. Prugh

23 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John D. Prugh United States 13 280 178 95 75 73 23 528
I. J. GALPIN United Kingdom 15 137 0.5× 390 2.2× 38 0.4× 45 0.6× 50 0.7× 51 564
Ichiro Muramatsu Japan 15 219 0.8× 411 2.3× 106 1.1× 26 0.3× 28 0.4× 70 635
Jill Gigg Tanzania 15 400 1.4× 343 1.9× 31 0.3× 9 0.1× 57 0.8× 37 686
István Schön Hungary 15 255 0.9× 469 2.6× 24 0.3× 69 0.9× 15 0.2× 44 654
Subhasish Tapadar United States 16 300 1.1× 469 2.6× 60 0.6× 32 0.4× 31 0.4× 25 689
Jürgen Eirich Germany 15 112 0.4× 412 2.3× 44 0.5× 14 0.2× 24 0.3× 40 589
Hélène Adihou Germany 12 212 0.8× 525 2.9× 87 0.9× 26 0.3× 15 0.2× 20 681
Yongbiao Guan United States 13 253 0.9× 255 1.4× 116 1.2× 43 0.6× 46 0.6× 22 639
Stuart Hazeldine United States 16 298 1.1× 408 2.3× 55 0.6× 55 0.7× 9 0.1× 20 758

Countries citing papers authored by John D. Prugh

Since Specialization
Citations

This map shows the geographic impact of John D. Prugh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Prugh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Prugh more than expected).

Fields of papers citing papers by John D. Prugh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John D. Prugh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Prugh. The network helps show where John D. Prugh may publish in the future.

Co-authorship network of co-authors of John D. Prugh

This figure shows the co-authorship network connecting the top 25 collaborators of John D. Prugh. A scholar is included among the top collaborators of John D. Prugh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John D. Prugh. John D. Prugh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Egbertson, Melissa S., Bohumil Bednář, Ben Askew, et al.. (2000). Nonpeptide GPIIB/IIIA receptor antagonists. Part 21: C-6 flexibility and amide bond orientation are important factors in determining the affinity of compounds for activated or resting platelet receptors. Bioorganic & Medicinal Chemistry Letters. 10(17). 1943–1948. 2 indexed citations
2.
Egbertson, Melissa S., Jacquelynn J. Cook, Bohumil Bednář, et al.. (1999). Non-Peptide GPIIb/IIIa Inhibitors. 20. Centrally Constrained Thienothiophene α-Sulfonamides Are Potent, Long Acting in Vivo Inhibitors of Platelet Aggregation. Journal of Medicinal Chemistry. 42(19). 4014–4014. 2 indexed citations
3.
Egbertson, Melissa S., Jacquelynn J. Cook, Bohumil Bednář, et al.. (1999). Non-Peptide GPIIb/IIIa Inhibitors. 20. Centrally Constrained Thienothiophene α-Sulfonamides Are Potent, Long Acting in Vivo Inhibitors of Platelet Aggregation. Journal of Medicinal Chemistry. 42(13). 2409–2421. 41 indexed citations
4.
Prugh, John D., Robert J. Gould, Robert J. Lynch, et al.. (1997). Nonpeptide GPIIB/IIIA inhibitors. 16. Thieno[2,3-b]thiophene α-sulfonamides are potent inhibitors of platelet aggregation. Bioorganic & Medicinal Chemistry Letters. 7(7). 865–870. 9 indexed citations
5.
Prugh, John D., Kimiko Della Croce, & R. B. Levine. (1992). Effects of the steroid hormone, 20-hydroxyecdysone, on the growth of neurites by identified insect motoneurons in vitro. Developmental Biology. 154(2). 331–347. 66 indexed citations
6.
Prugh, John D., et al.. (1992). A Simple Method of Protecting a Secondary Amine with Tert Butyloxycarbonyl (Boc) in the Presence of a Primary Amine. Synthetic Communications. 22(16). 2357–2360. 17 indexed citations
7.
Hartman, George D., Wasyl Halczenko, John D. Prugh, et al.. (1992). Thieno[2,3-b]furan-2-sulfonamides as topical carbonic anhydrase inhibitors. Journal of Medicinal Chemistry. 35(16). 3027–3033. 23 indexed citations
8.
Prugh, John D., George D. Hartman, Pierre Mallorga, et al.. (1991). New isomeric classes of topically active ocular hypotensive carbonic anhydrase inhibitors: 5-substituted thieno[2,3-b]thiophene-2-sulfonamides and 5-substituted thieno[3,2-b]thiophene-2-sulfonamides. Journal of Medicinal Chemistry. 34(6). 1805–1818. 97 indexed citations
9.
10.
11.
Prugh, John D., et al.. (1989). A Convenient and Unambiguous Synthesis of 2 (or 7)-Chloronaphthalenes from Substituted α-Tetralones. Synthesis. 1989(7). 554–556. 7 indexed citations
12.
13.
Prugh, John D., C. S. ROONEY, A. A. Deana, & Harri G. Ramjit. (1986). Synthesis and utilization of the chiral synthon methyl 3-O-benzyl-2,4,6-trideoxy-6-iodo-.alpha.-D-erythro-hexopyranoside in the synthesis of a potent HMG-CoA reductase inhibitor. The Journal of Organic Chemistry. 51(5). 648–657. 13 indexed citations
14.
STOKKER, G. E., William F. Hoffman, Alfred W. Alberts, et al.. (1985). 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. I. Structural modification of 5-substituted 3,5-dihydroxypentanoic acids and their lactone derivatives. Journal of Medicinal Chemistry. 28(3). 347–358. 84 indexed citations
15.
Prugh, John D., Robert L. Smith, Byron H. Arison, & Graham Smith. (1985). Oxygenated chimpanzee metabolites of [(2-cyclopentyl-6,7-dichloro-2-methyl-1-oxo-5-indanyl)oxy]acetic acid (MK-473): their structural elucidation and synthesis. The Journal of Organic Chemistry. 50(19). 3490–3498. 1 indexed citations
16.
Bolhofer, William A., A. A. Deana, Charles N. Habecker, et al.. (1983). Inhibitors of gastric acid secretion: antisecretory 2-pyridylurea derivatives. Journal of Medicinal Chemistry. 26(4). 538–544. 12 indexed citations
17.
Prugh, John D. & A. A. Deana. (1982). Methyl 3-0-benzyl-2,4,6-trideoxy-6-iodo-α-d--hexopyranoside, a chiral synthon for the synthesis of inhibitors of HMG-CoA reductase. Tetrahedron Letters. 23(3). 281–284. 20 indexed citations
18.
Prugh, John D., et al.. (1966). Heterocyclic Amines. III. 3-Dimethylaminofuran1. Journal of Medicinal Chemistry. 9(2). 254–255. 1 indexed citations
19.
Prugh, John D., et al.. (1966). The oxidation of acetals with n-bromosuccinimide. Tetrahedron Letters. 7(13). 1351–1356. 25 indexed citations
20.
Prugh, John D., et al.. (1964). The Synthesis and Proton Magnetic Resonance Spectra of Some Brominated Furans1. The Journal of Organic Chemistry. 29(7). 1991–1994. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by I. J. GALPIN Breakdown of academic impact, for papers by Ichiro Muramatsu Breakdown of academic impact, for papers by Jill Gigg Breakdown of academic impact, for papers by István Schön Breakdown of academic impact, for papers by Subhasish Tapadar Breakdown of academic impact, for papers by Jürgen Eirich Breakdown of academic impact, for papers by Hélène Adihou Breakdown of academic impact, for papers by Yongbiao Guan Breakdown of academic impact, for papers by Stuart Hazeldine
Rankless by CCL
2026